menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Mural Health, ICON Partner to Enhance Site Experience in Trials

    CONTRACTPHARMA

    ICON Reports Fourth Quarter and Full Year 2024 Results

    BUSINESSWIRE

    ICON plc Schedules Q4 & Full Year 2024 Earnings Conference Call

    BUSINESSWIRE

    ICON Issues Financial Guidance for Full Year 2025

    BUSINESSWIRE

    ICON plc to Present at the 43rd Annual J.P. Morgan Conference

    BUSINESSWIRE

    ICON and Employees Honored for Excellence in Clinical Research

    BUSINESSWIRE

    ICON Announces Appointment of Chief Operating Officer

    BUSINESSWIRE

    ICON plc to Present at the Jefferies London Healthcare Conference

    BUSINESSWIRE

    ICON Reports Third Quarter 2024 Results

    BUSINESSWIRE

    ICON plc Schedules Third Quarter 2024 Earnings Conference Call

    BUSINESSWIRE

    ICON Survey Shows Focus On Precision Therapies In Oncology

    BUSINESSWIRE

    ICON plc to Present at the Baird 2024 Global Healthcare Conference

    BUSINESSWIRE

    ICON plc Schedules Second Quarter 2024 Earnings Conference Call

    BUSINESSWIRE

    ICON plc to Present at the Jefferies Global Healthcare Conference

    BUSINESSWIRE

    ICON Hosts Investor Day and Updates Full Year 2024 Financial Guidance

    BUSINESSWIRE

    ICON Announces CFO Transition

    BUSINESSWIRE

    ICON plc Schedules First Quarter 2024 Earnings Conference Call

    BUSINESSWIRE

    ICON plc to Present at Upcoming Investor Conferences

    BUSINESSWIRE

    ICON Reports Fourth Quarter and Full Year 2023 Results

    BUSINESSWIRE

    ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call

    BUSINESSWIRE

    ICON Issues Financial Guidance for Full Year 2024

    BUSINESSWIRE

    Biotech companies to increase R&D spend

    BUSINESSWIRE

    ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference

    BUSINESSWIRE

    ICON Secures Upgraded Credit Rating from Moody’s Investors Service

    BUSINESSWIRE

    ICON Reports Third Quarter 2023 Results

    BUSINESSWIRE

    Icon, Saphetor partner on trials targeting precision medicine

    FIERCE BIOTECH

    ICON Secures Upgraded Credit Rating from S&P Global Ratings

    BUSINESSWIRE

    ICON plc Schedules Third Quarter 2023 Earnings Conference Call

    BUSINESSWIRE

    ICON Releases Expanded End-to-end Clinical Trial Tokenisation Solution

    BUSINESSWIRE

    ICON Reports Second Quarter 2023 Results

    BUSINESSWIRE

    ICON Shareholders Vote in Favour of All Resolutions at Annual General Meeting

    BUSINESSWIRE

    ICON plc Schedules Second Quarter 2023 Earnings Conference Call

    BUSINESSWIRE

    ICON plc Set to Join Russell 3000® Index

    BUSINESSWIRE

    ICON plc to Attend Upcoming Investor Conferences

    BUSINESSWIRE

    ICON plc Schedules First Quarter 2023 Earnings Conference Call

    BUSINESSWIRE

    LEO Pharma, ICON Partner to Advance Clinical Trials in Dermatology

    CONTRACT PHARMA

    ICON plc to Present at Upcoming Investor Conferences

    BUSINESSWIRE

    ICON Reports Fourth Quarter and Full Year 2022 Results

    BUSINESSWIRE

    ICON recognised as leading CRO and employer by Scrip, Fierce Life Sciences

    BUSINESSWIRE

    ICON plc to Present at the 2022 Evercore ISI HealthCONx Conference

    BUSINESSWIRE

    ICON plc Selected by BARDA to Execute Anthrax Vaccine Clinical Trial

    CONTRACTPHARMA

    ICON Releases its 2021 ESG Report

    BUSINESSWIRE

    ICON plc to Present at the 2022 Wells Fargo Healthcare Conference

    BUSINESSWIRE

    ICON Reports Second Quarter 2022 Results

    BUSINESSWIRE

    ICON Shareholders Vote in Favour of All Resolutions at its AGM

    BUSINESSWIRE

    ICON plc Schedules Second Quarter 2022 Earnings Conference Call

    BUSINESSWIRE

    ICON to present at the H.C. Wainwright Conference and the Jefferies Conference

    BUSINESSWIRE

    ICON plc to present at the BofA Securities 2022 Healthcare Conference

    BUSINESSWIRE

    ICON Reports First Quarter 2022 Results

    BUSINESSWIRE

    Decentralized trials, broader services key trends for CROs

    FIERCEBIOTECH

    ICON Announces the Expansion of its Accellacare Site Network

    BUSINESSWIRE

    ICON acquisition creates world-leading healthcare intelligence and CRO

    BIOSPACE

    Mylan to Acquire the Global Mkt Rights to a Once-monthly Glatiramer Acetate Mapi

    PR NEWSWIRE

    Icon focused on smooth transition, minimal turnover, CEO on Mapi acquisition

    OUTSOURCING

    ICON Acquires Mapi Group

    PHARMATECHGLOBAL

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.